A new bleeding control tool called Traumagel, which earned the Food and Drug Administration’s medical device clearance on Wednesday, could change how first responders address severe bleeding.
FDA Approves Algae- and Fungi-Based Bleeding Control Gel
Traumagel, which will launch later this year, is a 30-ml syringe of an algae- and fungi-based hemostatic gel that’s the color and texture of hummus. It can be applied directly into a wound, helping stanch bleeding within seconds.

Traumagel is a new hemostatic agent that has just been approved by the FDA.
Cresilon
Traumagel, which will launch later this year, is a 30-ml syringe of an algae- and fungi-based hemostatic gel that’s the color and texture of hummus. It can be applied directly into a wound, helping stanch bleeding within seconds. The FDA cleared its use for moderate to severe bleeding, Fast Company reports.
Joe Landolina, founder of Brooklyn-based Cresilon , which makes Traumagel, says that in addition to stopping bleeding quickly, the product’s “flowable” properties can improve the safety of treating something like a gunshot wound.
Cresilon says it is focused on Traumagel’s launch, and getting EMTs and physicians trained to use it.